Cormorant Asset Management, LP MLTX Holdings History
Cormorant Asset Management, LP's MoonLake Immunotherapeutics Holding Summary
As of 2025-03-31, Cormorant Asset Management, LP held 8.49 Mil shares of MoonLake Immunotherapeutics(MLTX), totaling $331.87 Mil. This investment constitutes 24.95% of their stock portfolio, and Cormorant Asset Management, LP now holds 13.38% of the outstanding MoonLake Immunotherapeutics(MLTX) stock.
The initial trade took place in 2022Q2. And since then Cormorant Asset Management, LP has made 4 purchases of MLTX, at an average price of $12.02, for a total of 8.49 Mil shares. Based on historical transaction data and MLTX's current price of $53.09, Cormorant Asset Management, LP's estimated gain on his MLTX holdings is $348.87 Mil, reflecting a 341.75% gain to date.
Cormorant Asset Management, LP MLTX ($53.09) Holding Chart
Cormorant Asset Management, LP MLTX ($53.09) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
